Explore Key Insights from the second quarterly meeting of the MDIC Commercial Payer Council, held on April 2, 2024. MDIC’s Health Economics and Patient Value (HEPV) program served as a neutral convener, bringing together executives representing an integrated healthcare delivery network and payer, a device company, a health plan, a health technology assessment organization, and a law firm, as well as consultants involved in health policy, market access, and reimbursement.
The experts shared their perspectives and insights on two timely topics:
1. Utilization management (UM), prior authorization (PA), and health equity in Medicare Advantage 2. The impact of new obesity drugs on the medical device industry: Payers’ Views on the Current Rise and Future of Obesity Drug Coverage
The following key insights are intended to help individuals working in device and digital health technology companies develop a strategy and pathway for working with commercial payers.
